BMY

#129
Bristol-Myers Squibb Co.
58.04 USD
+0.28%
Setor: Cuidados de saúde
Base: USD
Moeda do lucro: USD
Faixa diária
58.01
58.67
Faixa anual
42.52
62.89
Mudança diária
+0.28%
Mudança mensal
-3.25%
Mudança em 6 meses
+34.23%
Mudança anual
+18.02%
Fechamento anterior
57.88
Abrir
58.48
Bid
Ask
Mínimo
58.01
High
58.67
Volume
745
Abrir gráfico completo

Financials

Visão geral Relatórios Estatísticas Dividendos
Trimestral Ano
  • Market Capitalization 118.2 B
  • Employee 33 K
  • Founded N/A
  • CEO Chris Boerner
  • Website www.bms.com
  • Headquarter Delaware, United States
  • FIGI BBG000DQLV23
  • Industry Fabricantes de medicamentos - gerais
Receita total
Lucro líquido
Lucro básico por ação
Dívida total
Fluxo de caixa livre
Caixa e equivalentes de caixa
Índice preço/lucro
15.59
Índice preço/fluxo de caixa
2.28
Dividendos por ação
2.49
Rendimento de dividendos, %
4.62

Bristol-Myers Squibb Company

Bristol-Myers Squibb Company, doing business as Bristol Myers Squibb, is an American multinational pharmaceutical company headquartered in Princeton, New Jersey. The company's primary products are apixaban for people with atrial fibrillation; nivolumab, used to treat certain types of cancer; lenalidomide, used to treat multiple myeloma, smoldering myeloma, and myelodysplastic syndromes; abatacept, used to treat autoimmune diseases such as rheumatoid arthritis; pomalidomide, an anti-cancer medication used for the treatment of multiple myeloma and AIDS-related Kaposi sarcoma; ipilimumab, to treat cancer; and luspatercept for the treatment of anemia in beta thalassemia and myelodysplastic syndromes. In 2024, 71% of the company's revenues came from the United States. The company is ranked 94th on the Fortune 500 and 173rd on the Forbes Global 2000.

Notícias